Alzheimer Disease Clinical Trial
— PICTOfficial title:
The Pain Identification and Communication Toolkit: A Training Program to Support Family Caregivers of Persons With ADRD
This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techniques. It will recruit participants from programs of all-inclusive care for the elderly (PACE). The investigators hypothesize that PICT will help caregivers to recognize and communicate about pain in their care recipients.
Status | Recruiting |
Enrollment | 440 |
Est. completion date | February 2028 |
Est. primary completion date | November 1, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility | CAREGIVER PARTICIPANTS Inclusion Criteria: 1. Age 21 or older 2. Any gender 3. English speaking 4. Cognitively intact (BOMC =10) 5. Provides care to a person with dementia or cognitive impairment who also has a pain diagnosis 6. Provides care to a PACE participant 7. Care recipient is not enrolled in hospice 8. Visits the care recipient at least weekly 9. Accessible by telephone Exclusion Criteria: 1. Paid caregiver 2. Age 20 or younger 3. Non-English speaking 4. Cognitively impaired 5. Does not provide care to a person with dementia or cognitive impairment who also has a pain diagnosis 6. Does not provide care to a PACE participant 7. Currently enrolled in hospice 8. The patient to whom the caregiver provides assistance is enrolled in hospice 9. Visits care recipient less than weekly 10. Not accessible by telephone. PATIENT PARTICIPANTS Inclusion Criteria: 1. Currently enrolled at a PACE program 2. Record of dementia or cognitive impairment 3. Diagnosis of pain 4. Responsive to environment 5. No terminal illness with life expectancy <6 months 6. Not in active cancer treatment Exclusion Criteria: 1. Not enrolled at a PACE program 2. No dementia or cognitive impairment 3. Unresponsive to environment 4. Has terminal illness with life expectancy <6 months 5. Is in active cancer treatment 6. Enrolled in hospice |
Country | Name | City | State |
---|---|---|---|
United States | Weill Cornell Medicine | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Weill Medical College of Cornell University | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in caregiver-reported pain communication | Change in caregiver-reported pain-related communication as measured by ten questions from the Perceived Involvement in Care Scale (PICS). The range of possible scores is 10-50, where higher scores indicate greater caregiver involvement in patient consultation. | Baseline, 1 month, 3 month, 6 month | |
Primary | Change in pain management discussions with health care providers | Change in pain management discussions as measured by the combined number of phone calls and appointments made to discuss pain management recorded in the patient's medical chart. | Baseline, 1 month, 3 month, 6 month | |
Primary | Change in concordance between patient and caregiver pain ratings | Change in concordance in patient and caregiver pain ratings as measured by the absolute difference between caregiver and patient pain ratings of the patient's pain on the Iowa Pain Thermometer (IPT). The IPT is scored on a scale of 0-10 where 0 means "no pain" and 10 means "the most intense pain imaginable." | Baseline, 1 month, 3 month, 6 month | |
Primary | Change in caregiver's ability to recognize pain | Change in caregiver's ability to recognize pain as measured by the absolute difference between the caregiver-reported PAINAD score and correct PAINAD score (i.e. absolute value of the deviance between the scores). The PAINAD is scored on a scale from 0-10 where 0 means "no pain" and 10 means "severe pain." Participants will be shown multiple videos on which to score the PAINAD. | Baseline, 1 month, 3 month, 6 month | |
Primary | Change in caregiver's ability to recognize pain behaviors | Change in caregiver's ability to recognize pain behaviors as measured by the absolute difference between the number of caregiver-reported behaviors within each of the 5 PAINAD behaviors (i.e., Breathing, Negative Vocalization, Facial Expression, Body Language, Consolability) and correct number of behaviors. Participants will be shown multiple videos on which to score the PAINAD. | Baseline, 1 month, 3 month, 6 month | |
Secondary | Change in patient's behavioral disturbance | Change in patient's behavioral disturbance as measured by 11 items on the Memory and Behavior Problem Checklist. Questions are asked on a likert scale of 0-never occurs to 4-occurs daily or more often for a total possible score of 44, with higher scores indicating more behavioral disturbance in the patient. | Baseline, 1 month, 3 month, 6 month | |
Secondary | Change in patient's pain treatments or regimens | Change in number of each type of caregiver-reported patient treatment/regimens. | Baseline, 1 month, 3 month, 6 month | |
Secondary | Change in caregiver burden | Change in caregiver burden will be assessed by the 7-item version of the Zarit Burden Index (ZBI). Response options for each item range from 0-"never" to 4-"nearly always". The highest possible score is 28 and the lowest possible score is 0; higher scores indicate more caregiver burden. | Baseline, 1 month, 3 month, 6 month | |
Secondary | Change in caregiver distress level | Change in caregiver distress as measured by 11 items on the Memory and Behavior Problem Checklist. Questions are asked on a likert scale of 0-not at all to 4-extremely for a highest possible score of 44 and a lowest possible score of 0, with higher scores indicating more caregiver distress. | Baseline, 1 month, 3 month, 6 month | |
Secondary | Change in caregiver self-efficacy in pain recognition | Change in caregiver self-efficacy in pain recognition as measured by 9 items adapted from The Health Education Impact Questionnaire on a scale of 1-"completely disagree" to 5-"completely agree" with a highest total score of 45 and a lowest total score of 9. Higher total scores indicate higher self-efficacy in pain recognition. | Baseline, 1 month, 3 month, 6 month | |
Secondary | Change in caregiver self-confidence in recognizing pain | Change in self-confidence in recognizing pain as measured by four items adapted from McCabe et al., 2012. Questions are asked on a scale of 1-"not at all confident" to 4-"very confident," with a highest possible score of 16 and a lowest possible score of 4. Higher scores indicate more confidence in ones ability to recognize pain. | Baseline, 1 month, 3 month, 6 month | |
Secondary | Change in caregiver self-efficacy in pain-related communication | Change in caregiver self-efficacy in pain-related communication as measured by a modified 10-item version of the Perceived Efficacy in Patient-Physician Interactions (PEPPI) Scale. Questions are asked on a scale of 1 - "not at all confident" to 5 - "very confident" with a highest total score of 50 and a lowest total score of 10. Higher scores indicate higher self-efficacy in pain-related communication between a caregiver and a healthcare provider. | Baseline, 1 month, 3 month, 6 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |